From: Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study
48 Gy/4 Fr (n = 6)
50 Gy/4 Fr (n = 51)
52 Gy/4 Fr (n = 14)
OS (%) at 3/5 years
100/100
70/65
71/53
PFS (%) at 3/5 years
83/63
62/55
64/54
Cumulative incidence of LR (%) at 3/5 years
0/20
10/10
22/31